Rafferty Asset Management
HAE icon

Rafferty Asset Management’s Haemonetics HAE Stock Holding History

Rafferty Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,769
Closed -$266K – 1311
2021
Q3 		$266K Buy
+3,769
New +$238K ﹤0.01% 1150

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rafferty Asset Management's HAE Position: Q4 2021 in Review

Rafferty Asset Management sold out of Haemonetics (HAE) in Q4 2021, closing a stake of 3,769 shares — an estimated $266K sold.

Rafferty Asset Management first reported a position in HAE in Q3 2021 and held it in 1 quarter. The position peaked at $266K in Q3 2021. 257 funds tracked by Wall St. Rank hold HAE as of Q4 2021.

  • Rafferty Asset Management reported no remaining Haemonetics position as of Q4 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 3,769 Haemonetics shares in Q4 2021, an estimated $266K.
  • Rafferty Asset Management first reported a position in Haemonetics in Q3 2021 and held it in 1 quarter.
  • Rafferty Asset Management's Haemonetics position peaked at $266K in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Haemonetics as of Q4 2021.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.